Genetic testing in motor neurone disease

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), has a genetic basis in 10%-15% of cases.
• The C9ORF72 gene is the most common hereditary cause of ALS and can be linked to frontotemporal dementia.

Purpose of the Study:

• To highlight the increasing importance of genetic testing in ALS diagnosis.
• To discuss the potential risks and ethical considerations of genetic screening in ALS.
• To emphasize the need for neurologists to understand the role of genetic testing in MND.

Main Methods:

• Review of current genetic testing practices in ALS.
• Analysis of hereditary factors and genetic variants in ALS.
• Discussion of clinical genetics and neurological disorder implications.

Main Results:

• Emerging therapies necessitate routine genetic testing for ALS patients.
• Genetic screening poses risks due to incomplete penetrance and unknown significance of variants.
• The C9ORF72 gene expansion is a significant hereditary factor in ALS and frontotemporal dementia.

Conclusions:

• Genetic testing is becoming essential for ALS management and treatment stratification.
• Careful genetic screening is required to mitigate potential harm to patients and families.
• Neurologists require foundational knowledge of genetic testing in MND for comprehensive patient care.